Edition:
United Kingdom

Ono Pharmaceutical Co Ltd (4528.T)

4528.T on Tokyo Stock Exchange

2,678JPY
6:00am GMT
Change (% chg)

¥56 (+2.14%)
Prev Close
¥2,622
Open
¥2,632
Day's High
¥2,678
Day's Low
¥2,632
Volume
2,104,500
Avg. Vol
2,352,715
52-wk High
¥2,734
52-wk Low
¥2,185

Chart for

About

ONO PHARMACEUTICAL CO., LTD. is a Japan-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates in one business segment. The Pharmaceutical segment involves in the manufacture and sale of drugs for medical and general use. The Company also involves in the clinical development,... (more)

Overall

Beta: 0.46
Market Cap(Mil.): ¥1,507,859.00
Shares Outstanding(Mil.): 589.24
Dividend: 20.00
Yield (%): 1.56

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.58
EPS (TTM): -- -- --
ROI: -- 14.84 10.60
ROE: -- 16.32 14.19

BRIEF-Ono Pharmaceutical enters into license agreement with Bristol-Myers Squibb for Prostaglandin E2 receptor antagonists

* Says it entered into license agreement with Bristol-Myers Squibb Company (BMS)for Prostaglandin E2 receptor antagonists relating to Immuno-Oncology programs

14 Dec 2017

BRIEF-Bristol-Myers Squibb Granted Exclusive License By Ono Pharmaceutical For Multiple Programs Targeting Immuno-Suppressive Factors In The Tumor Microenvironment

* BRISTOL-MYERS SQUIBB GRANTED EXCLUSIVE LICENSE BY ONO PHARMACEUTICAL FOR MULTIPLE PROGRAMS TARGETING IMMUNO-SUPPRESSIVE FACTORS IN THE TUMOR MICROENVIRONMENT

13 Dec 2017

BRIEF-Ono Pharmaceutical completes retirement of treasury shares

* Says it completed retirement of 45.9 million shares (7.8 percent of outstanding) on Oct. 31

31 Oct 2017

BRIEF-Karyopharm and Ono Pharmaceutical sign exclusive license agreement to develop and commercialize Selinexor and KPT-8602 in Japan and other countries in Asia

* Karyopharm and Ono Pharmaceutical Co. Ltd. sign exclusive license agreement to develop and commercialize Selinexor and KPT-8602 in Japan and other countries in Asia

12 Oct 2017

BRIEF- Ono Pharmaceutical completes share repurchase

* Says it completes repurchase of 15.9 million shares of its common stock, for 38.77 billion yen in total, from June 14 to Sept. 29

02 Oct 2017

BRIEF-Array Biopharma reports Q4 loss per share $0.17

* Array Biopharma reports financial results for the fourth quarter and full year of fiscal 2017

09 Aug 2017

BRIEF-OncoTherapy Science says close of peptide vaccine related agreement with ONO PHARMACEUTICAL

* Says peptide vaccine related agreement with ONO PHARMACEUTICAL CO., LTD. will close on Sept. 4

02 Aug 2017

Earnings vs. Estimates